The therapeutic effects of induced pluripotent stem cell‐derived mesenchymal stem cells on Parkinson's disease

Documenti analoghi

• Retraction: miR ‐212/132 downregulates SMAD2 expression to suppress the G1 /S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells
  Pubblicazione: (2024)
• Microtubule depolymerization induces ferroptosis in neuroblastoma cells
  di: Mayuri Bandekar, et al.
  Pubblicazione: (2024)
• KGF secreted from HSCs activates PAK4/BMI1, promotes HCC stemness through PI3K/AKT pathway
  di: Qinghua Li, et al.
  Pubblicazione: (2024)
• Neuroprotection and mechanisms of ginsenosides in nervous system diseases: Progress and perspectives
  di: Li Zhou, et al.
  Pubblicazione: (2024)
• HucMSC extracellular vesicles increasing SATB 1 to activate the Wnt/β‐catenin pathway in 6‐OHDA‐induced Parkinson's disease model
  di: Ying He, et al.
  Pubblicazione: (2024)